Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Valeant Pharmaceuticals Intl Inc (VRX), International, Ltd. (ADR) (CTRP): Hound Partners’ Picks Absolutely Destroyed The Market in Q1

Jonathan Auerbach’s Hound Partners had a very strong first quarter based on the 19 long positions in companies with a market cap of $1 billion or greater that it reported ownership of as of the end of 2014 in its latest 13F filing. The weighted average returns from those 19 positions was a hefty 12.7%, which left Hound Partners just outside the top 40 best performing funds for the first quarter, according to that metric, but in the upper 5% of performers among the more than 700 funds that we track. Among the fund’s top performing positions last quarter were Valeant Pharmaceuticals Intl Inc (NYSE:VRX), International, Ltd. (ADR) (NASDAQ:CTRP), Tesoro Corp. (NYSE:TSO), Spirit AeroSystems Holdings, Inc. (NYSE:SPR), and Informatica Corporation (NASDAQ:INFA).

Hound Partners is one of the more than 700 hedge funds we track at Insider Monkey in order to analyze their returns and identify their most popular small-cap picks collectively. We gather this data because we found through extensive backtesting that the 15 most popular small-caps of hedge funds had a high probability of outperforming the market and doing far better than their own large-cap picks, which underperform the market (and yet get the bulk of their capital). Since launching this small-cap strategy at the end of August 2012 it has generated returns of more than 137%, including 5.5% in the first quarter of 2015, outperforming the market by more than 82 percentage points since inception (read the latest details).

Let’s start with Valeant Pharmaceuticals Intl Inc (NYSE:VRX), which was Hound Partners’ third-largest long position heading into 2015, as it held 2.51 million shares of the Canadian pharmaceutical company. Valeant’s stock exploded during the first quarter gaining 38.79%, making it one of the biggest large-cap gainers of the year thus far. The company’s winning bid for Salix Pharmaceuticals in March, which may have also convinced activist investor Bill Ackman to take a large stake in the company shortly afterwards, was one of the key drivers of the stock during the quarter. Jeffrey Ubben and billionaires Andreas Halvorsen and Stephen Mandel all had large positions in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) entering the lucrative quarter. International, Ltd. (ADR) (NASDAQ:CTRP), the Chinese travel and accommodations website also proved to be a lucrative investment this past quarter for its investors, which included Hong Kong billionaire Lei Zhang, who achieved impressive first quarter returns of 22.8% from his 13 long positions, of which was one of the largest. While it was only middle of the pack in terms of Hound Partners’ portfolio with its 1.53 million share position representing 1.99% of the fund’s portfolio, it did well to increase its stake in the company by 58% during the fourth quarter. International, Ltd. (ADR) (NASDAQ:CTRP) enjoyed its trip up the valuation charts, as its stock rose by 28.84% last quarter. John Thaler’s JAT Capital Management also had a large position in, the largest of any fund in our database.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.